Capital will enable continued advancement of novel Proteograph™ platform and commercialization of first-in-class proteomics products Seer, Inc., a life sciences company focused on capturing and translating proteome insights to advance human health, today announced it has raised $55 million in an oversubscribed Series D equity financing. The round was led by healthtech and life sciences […]
WELLESLEY, Mass., GARDNER, Mass. and LOUISVILLE, Ky. — Ampersand Capital Partners announced today that it has completed the acquisition of Peptides International and merged it with existing portfolio company New England Peptide. This merger brings together two leading providers of peptide synthesis services as well as a broad catalog of unique peptide products to assist in […]
SEATTLE — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue biopsy analysis platforms with emphasis on rare cell detection announced today the completion of a $22M financing from new and existing investors. The funding will drive a global sales expansion for its instrument and consumables platform used in research […]
Consortium Plans to Apply Spatial Analysis to Major Challenges in Breast Cancer Research SEATTLE–(BUSINESS WIRE)–Dec. 11, 2019– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the formation of the GeoMx™ Breast Cancer Consortium (GBCC). The consortium is focused on using the GeoMx Digital Spatial Profiler to address some of the most challenging […]
LUND, Sweden–Genovis enzymes are used as platform methods in analytical workflows using mass spectrometry within the biopharma industry. Immobilized SialEXO benefits mass spectrometry but will significantly impact analytical workflows using capillary electrophoresis (CE). Charge variants of proteins are often analyzed using CE and the technology is well established for protein analysis and quality control. From our […]
SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an expanded antibody optimization collaboration with Pandion Therapeutics. Based on the successful completion of its first project for Pandion, Twist Biopharma, a division of Twist Bioscience, will apply […]
PARIS — Stilla Technologies, the provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director. These hires come at a time of […]
SAN DIEGO, CA — GEDmatch, a pioneer in consumer genealogy, today announced that it has joined with forensic genomics firm Verogen, Inc. in a move that allows the company to ensure ongoing privacy protections and enhance the customer experience for users of its website. “I am confident that we have found an ideal partner for […]
Wädenswil/Zurich, Switzerland – Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020. After seven years in the position, Matyas Vegh has decided to pursue new opportunities outside the company. “I am grateful to Matyas for his […]
CytoSure NGS – Combining the benefits of microarrays and NGS in a single assay Oxford, UK – Oxford Gene Technology (OGT), A Sysmex Group Company, has developed a breakthrough targeted NGS panel for constitutional cytogenetics research. The new CytoSure™ NGS panel—launching early in 2020—will combine the strengths of microarrays and NGS to deliver a comprehensive all-in-one assay. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
